Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
23.03
+1.27 (5.84%)
At close: Oct 6, 2025, 4:00 PM EDT
23.03
0.00 (0.00%)
After-hours: Oct 6, 2025, 4:10 PM EDT

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
Immune-based Therapies
5.00M
Log In
Immune-based Therapies Growth
-90.00%
Log In

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023
Period Ending
Dec '24 Dec '23
United States
5.00M
Log In
United States Growth
-90.00%
Log In